<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the frequency and spectrum of oral manifestations of HIV-infected drug-users in the Perm region </plain></SENT>
<SENT sid="1" pm="."><plain>SUBJECTS: 104 seropositive HIV-infected drug-users (69 male, 35 female; ages 15 to 32 years; 13 co-infected with <z:hpo ids='HP_0012115'>hepatitis</z:hpo> viruses) and 13 AIDS-infected drug-users (7 male, 6 female; ages 16 to 37 years; 12 co-infected with <z:hpo ids='HP_0012115'>hepatitis</z:hpo> viruses) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The most frequent forms of oral mucosal lesions in the HIV-infected group -- <z:e sem="disease" ids="C0006840" disease_type="Disease or Syndrome" abbrv="">candidiasis</z:e> (32.7%), herpetic lesions (15.4%), <z:hpo ids='HP_0100825'>cheilitis</z:hpo> glandularis (3.9%), <z:hpo ids='HP_0011107'>recurrent aphthous stomatitis</z:hpo> (2%) </plain></SENT>
<SENT sid="3" pm="."><plain>Regional <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> was observed in 31% cases </plain></SENT>
<SENT sid="4" pm="."><plain>The ulceronecrotic oral mucosal lesions were seen in the sublingual region and tongue in 11.5% patients and manifested with pain, <z:hpo ids='HP_0001260'>dysarthria</z:hpo>, <z:hpo ids='HP_0002015'>dysphagia</z:hpo>, and dysgeusia </plain></SENT>
<SENT sid="5" pm="."><plain>These lesions were found in drug-users who injected the opioids sublingually </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> patients had <z:e sem="disease" ids="C0006849" disease_type="Disease or Syndrome" abbrv="">oral candidiasis</z:e> (84.6%), herpetic lesions (53.8%), <z:hpo ids='HP_0011107'>recurrent aphthous stomatitis</z:hpo> (15.4%) and <z:hpo ids='HP_0100825'>cheilitis</z:hpo> glandularis (7%) </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-patients had severe <z:hpo ids='HP_0000217'>xerostomia</z:hpo>, and 15.4% had unilateral or bilateral swelling of the parotid glands </plain></SENT>
<SENT sid="8" pm="."><plain>Generalized ulceronecrotic <z:e sem="disease" ids="C0149704" disease_type="Disease or Syndrome" abbrv="">gingivostomatitis</z:e> was found in 50% of the patients but the sublingual ulceronecrotic lesions were not identified </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: 1 </plain></SENT>
<SENT sid="10" pm="."><plain>The spectrum of oral cavity lesions of HIV/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> patients in Perm region is widespread enough </plain></SENT>
<SENT sid="11" pm="."><plain>2 </plain></SENT>
<SENT sid="12" pm="."><plain>Dissemination of oral cavity lesions is increasing in proportion of disease progression </plain></SENT>
<SENT sid="13" pm="."><plain>3 </plain></SENT>
<SENT sid="14" pm="."><plain>Dental care of HIV/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> patients should include periodic oral examinations to monitor their disease progression and to alleviate symptoms of oral opportunic and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">neoplastic diseases</z:e>, to improve the life-style of the patients infected with HIV </plain></SENT>
</text></document>